Clinical Trials Browser

Phase 1/2 × Interventional × vorolanib × Clear all

NCT06577961 2024-08-29

Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients

Phase 1/2 Not yet recruiting

Carcinoma, Renal Cell, Kidney Neoplasms